What Apogee Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 11 | 83 |
| Total trades | 29 | 110 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 50,458 | 98,553 |
| Disposed | 3,786,091 | 5,816,586 |
| Net activity | −3,735,633 | −5,718,033 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Dambkowski Carl | Chief Medical Officer | Sep 03 | Disposition to Issuer · D | −167,123 | — | — | 0 |
| Fox Jennifer A. | Director | Sep 03 | Disposition to Issuer · D | −34,824 | — | — | 0 |
| McKenna Mark C. | Director | Sep 03 | Disposition to Issuer · D | −20,000 | — | — | 0 |
| Jones William A Jr | Director | Sep 03 | Disposition to Issuer · D | −34,824 | — | — | 0 |
| Fairmount Funds Management Llc | Director | Sep 03 | Disposition to Issuer · D | −51,166 | — | — | 0 |
| Fairmount Funds Management Llc | Director | Sep 03 | Disposition to Issuer · D | −51,166 | — | — | 0 |
| Fairmount Funds Management Llc | Director | Sep 03 | Disposition to Issuer · D | −340,855 | — | — | 0 |
| Henderson Michael Thomas | Chief Executive Officer | Sep 03 | Disposition to Issuer · D | −920,941 | — | — | 0 |
| Shah Nimish P | Director | Sep 03 | Disposition to Issuer · D | −1,750,000 | $135.11 | −$236M | 0 |
| Henderson Jane | Chief Financial Officer | Sep 03 | Disposition to Issuer · D | −158,371 | — | — | 0 |
| Dambkowski Carl | Chief Medical Officer | Sep 02 | Disposition to Issuer · D | −1,375 | $135.06 | −$186K | 167,123 |
| Fairmount Funds Management Llc | Director | Aug 07 | Exercise / conversion · M | +10,370 | $43.85 | +$455K | 340,855 |
| Fairmount Funds Management Llc | Director | Aug 07 | Exercise / conversion · M | +31,838 | $17.00 | +$541K | 330,485 |
| Dambkowski Carl | Chief Medical Officer | Aug 05 | Open-market sale · S | −5,500 | $134.17 | −$738K | 168,498 |
| Dambkowski Carl | Chief Medical Officer | Aug 05 | Exercise / conversion · M | +4,125 | $22.86 | +$94.3K | 173,998 |
| Henderson Jane | Chief Financial Officer | Jul 24 | Gift · G | −15,000 | — | — | 158,371 |
| Dambkowski Carl | Chief Medical Officer | Jul 14 | Gift · G | −8,000 | — | — | 169,873 |
| Henderson Michael Thomas | Chief Executive Officer | Jul 10 | Gift · G | −75,046 | — | — | 920,941 |
| Henderson Michael Thomas | Chief Executive Officer | Jul 08 | Open-market sale · S | −20,000 | $133.63 | −$2.67M | 995,987 |
| Dambkowski Carl | Chief Medical Officer | Jul 01 | Open-market sale · S | −5,500 | $132.74 | −$730K | 177,873 |
Loading...